Contents
Foreword to the First Edition -- Michel Glauser and Philippe Moreillon
Foreword to the First Edition, Revised -- Jacques Acar
Foreword to the Second Edition -- Stuart Levy
Preface
1 Historical Review of Antibacterial Chemotherapy [A. Bryskier]
2 Antibiotics and Antibacterial Agents: Classifications and Structure-Activity Relationship [A. Bryskier]
3 Epidemiology of Resistance to Antibacterial Agents [A. Bryskier]
4 Development of an Antibiotic: Microbiology [A. Bryskier]
5 Penicillins [A. Bryskier]
6 Cephems for Parenteral Use [A. Bryskier, J. Aszodi]
7 Oral Cephalosporins [A. Bryskier, M. Lebel]
8 Carbapenems [A. Bryskier]
9 Penems [A. Bryskier]
10 Monocyclic [Beta]-Lactams [P. Le Noc]
11 [Beta]-Lactam Prodrugs [A. Bryskier]
12 Peptidoglycan Synthesis Inhibitors [A. Bryskier, C. Dini]
13 [Beta]-Lactamase Inhibitors [A. Kazmierczak]
14 [Beta]-Lactamase Inhibitors under Research [A. Bryskier, C. Couturier, J. Lowther]
15 [Gamma]-Lactams and Derivatives [A. Bryskier]
16 Aminocyclitol Aminoglycosides [P. Veyssier, A Bryskier]
17 Spectinomycin [A. Bryskier]
18 Macrolides [A. Bryskier, E. Bergogne-Bérézin]
19 Ketolides [A. Bryskier]
20 Streptogramins [A. Bryskier]
21 Lincosamines [A. Bryskier]
22 Oxazolidinones [A. Bryskier]
23 Fusidic Acid [A. Bryskier]
24 Tetracyclines [A. Bryskier]
25 Tetracyclines under Investigation [A. Bryskier]
26 Fluoroquinolones [A. Bryskier]
27 DNA Gyrase Inhibitors Other than Fluoroquinolones [A. Bryskier]
28 Codrugs [A. Bryskier]
29 Coumarin Antibiotics: Novobiocin, Coumermycin, Clorobiocin [A. Bryskier, M. Klich]
30 Peptide Antibiotics [A. Bryskier]
31 Glycopeptides and Lipoglycopeptides [A. Bryskier]
32 Ansamycins [A. Bryskier]
33 Phenicols [A. Fisch, A. Bryskier]
34 5-Nitroimidazoles [L. Dubreuil]
35 Dihydrofolate Reductase Inhibitors, Nitroheterocycles (Furans), and 8-Hydroxyquinolines [P. Veyssier, A. Bryskier]
36 Mupirocin [A. Bryskier]
37 Fosfomycin and Derivatives [E. Bergogne-Bérézin]
38 Orthosomycins [A. Bryskier]
39 Peptidyl Deformylase Inhibitors [A. Bryskier, J. Lowther]
40 Helicobacter pylori and Antibacterial Agents [A. Bryskier, J. Lowther, C. Couturier]
41 Microbial Efflux of Antibiotics and Inhibitors of Efflux Pumps [A. Bryskier]
42 Paldimycin [A. Bryskier]
43 Antituberculosis Agents [A. Bryskier, J. Grosset]
44 Fluoroquinolones and Tuberculosis: a Review [A. Bryskier, J. Lowther]
45 Antituberculosis Compounds under Investigation [A. Bryskier]
46 Antibacterial Treatment of Leprosy [J. Grosset]
47 Primycin [A. Bryskier]
48 Benzonaphthyridones [A. Bryskier]
49 Agents against Methicillin-Resistant Staphylococcus aureus [A. Bryskier]
50 Mutilins [A. Bryskier]
51 In Pursuit of New Antibiotics [A. Bryskier]
52 Systemic Antifungal Agents [R. Grillot, B. Lebeau]
53 Antifungal Targets and Research into Antifungal Agents [A. Bryskier]
54 Drug Interactions during Anti-Infective Treatments [O. Petitjean, P. Nicolas, M. Tod, C. Padoin, A. Jacolot]
55 Antibiotic Treatments and the Intestinal Ecosystem [A. Andremont]
56 Interaction between Antimicrobial Agents and the Oropharyngeal and Intestinal Normal Microflora [Å. Sullivan, C. Edlund, C. E. Nord]
57 Clinical Quality Assurance and the International Development of New Anti-Infective Agents [J. M. Husson, C. Lim, A. Bryskier]
Index